Intravenous iron replacement: Management in general practice

Australian Family Physician

Volumn 39, Issue 11, 2010, Pages 839-841

  Naim, Mark ^a   Hunter, Jennifer ^a  

^a Uclinic   (Australia)

Author keywords

Clinical evaluation; General practice; Hematologic disease; Iron deficiency

Indexed keywords

ANTIANEMIC AGENT; FERRIC ION; IRON POLYMALTOSE;

ADULT; AGED; ARTICLE; AUSTRALIA; CONFIDENCE INTERVAL; FEMALE; GENERAL PRACTITIONER; HUMAN; IRON DEFICIENCY ANEMIA; IRON INTAKE; MALE; MIDDLE AGED; PRIMARY HEALTH CARE;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA, IRON-DEFICIENCY; AUSTRALIA; CONFIDENCE INTERVALS; FEMALE; FERRIC COMPOUNDS; GENERAL PRACTITIONERS; HEMATINICS; HUMANS; IRON, DIETARY; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; YOUNG ADULT;

EID: 78650222463     PISSN: 03008495     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Australian Iron Status Advisory Panel, 2002. Available at www.ironpanel.org.au.
2. Cavill I. Iron status as measured by serum ferritin: the marker and its limitations. Am J Kidney Dis 1999;34(Suppl 2):S12-7.
3. Rushton DH, Dover R, Sainsbury AW, et al. Why should women have lower reference limits for haemoglobin and ferritin concentrations than men? BMJ 2001;322:1355-7.
4. Worwood M, Evans WD, Villis RJ, et al. Iron absorption from a natural mineral water (Spatone Iron-Plus). Clin Lab Haematol 1996;18:23-7.
5. Arthur CK, Isbister JP. Iron deficiency: misunderstood, misdiagnosed and mistreated. Drugs 1987;33:171-82.
6. Editorial. Iron deficiency in children: food for thought. Med J Aust 2001;174:162-3.
7. Schultz BM, Freedman ML. Iron deficiency in the elderly. Baillieres Clin Haematol 1987;1:291-313.
8. Dallman PR. Iron deficiency and the immune response. Am J Clin Nutr 1987;46:329-34.
9. Dhur A, Galan P, Hercberg S. Iron status, immune capacity and resistance to infections. Comp Biochem Physiol A 1989;94:9-11.
10. Bryce S. Lessons from East Arnhem Land. Improving adherence to chronic disease treatments. Aust Fam Physician 2002;31:617-21.
11. Bird S. Medication errors. Aust Fam Physician 2002;31:759.
12. Van Wyck DB, Cavallo G, Spinowitz BS, et al. Safety and efficacy of iron sucrose in patients sensitive to iron dextran: North American clinical trial. Am J Kidney Dis 2000;36:88-97.
13. Newnham E, Ahmad I, Thornton A, et al. Safety of iron polymaltose given as a total dose iron infusion. Intern Med J 2006;36:672-4.
14. al-Momen AK, al-Meshari A, al-Nuaim L, et al. Intravenous iron sucrose complex in the treatment of iron deficiency anemia during pregnancy. Eur J Obstet Gynecol Reprod Biol 1996;69:121-4.
15. Bastani B, Rahman S, Gellens M. Lack of reaction to ferric gluconate in hemodialysis patients with a history of severe reaction to iron dextran. ASAIO J 2002;48:404-6.
16. Hayat A. Safety issues with intravenous iron products in the management of anemia in chronic kidney disease. Clin Med Res 2008;6:93-102.
17. Anker SD, Comin Colet J, Filippatos G, et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 2009;361:2436-48.
18. Kociol RD, Newby LK. Ferric carboxymaltose improved symptoms and quality of life in patients with chronic heart failure and iron deficiency. Ann Intern Med 2010;152:JC4-5.
19. Okonko DO, Grzeslo A, Witkowski T, et al. Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial. Am Coll Cardiol 2008;51:103-12.
20. Gasche C, Dejaco C, Waldhoer T, et al. Intravenous iron and erythropoietin for anemia associated with Crohn disease. A randomized, controlled trial. Ann Intern Med 1997;126:782-7.
21. Gasche C, Dejaco C, Reinisch W, et al. Sequential treatment of anemia in ulcerative colitis with intravenous iron and erythropoietin. Digestion 1999;60:262-7.
22. Khalafallah A, Dennis A, Bates J, et al. A prospective randomized, controlled trial of intravenous versus oral iron for moderate iron deficiency anaemia of pregnancy. J Intern Med 2010 May 19 [Epub ahead of print].
23. Singh K, Fong YF. Intravenous iron polymaltose complex for treatment of iron deficiency anaemia in pregnancy resistant to oral iron therapy. Eur J Haematol 2000;64:272-4.
24. Singh K, Fong YF, Kuperan P. A comparison between intravenous iron polymaltose complex (Ferrum Hausmann) and oral ferrous fumarate in the treatment of iron deficiency anaemia in pregnancy. Eur J Haematol 1998;60:119-24.
25. Haines ML, Gibson PR. Delayed adverse reactions to total-dose intravenous iron polymaltose. Intern Med J 2009;39:252-5.
26. Manoharan A, Ramakrishna R, Pereira B. Delayed adverse reactions to total-dose intravenous iron polymaltose. Intern Med J 2009;39:857.
27. Charytan C, Levin N, Al-Saloum M, et al. Efficacy and safety of iron sucrose for iron deficiency in patients with dialysis-associated anemia: North American clinical trial. Am J Kidney Dis 2001;37:300-7.
28. Silva J, Andrade S, Ventura H, et al. Iron supplementation in haemodialysis: practical clinical guidelines. Nephrol Dial Transplant 1998;13:2572-7.
29. Saltissi D, Sauvage D, Westhuyzen J. Comparative response to single or divided doses of parenteral iron for functional iron deficiency in hemodialysis patients receiving erythropoietin. Clin Nephrol 1998;49:45-8.